The settlement ends two lawsuits that claimed that some of the products were “deceptively marketed, advertised, labeled, and sold as `Non-Drowsy,’” but actually contained dextromethorphan ...
Buyers of Robitussin can now apply to get money from a class-action lawsuit that began in 2022 over the cough medicine being marketed as "non-drowsy." Consumers can get $1.50 to $4.75 per claim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback